| Literature DB >> 2205380 |
A Rosolen1, L Whitesell, N Ikegaki, R H Kennett, L M Neckers.
Abstract
The N-myc gene is transiently expressed during normal embryonic development and abnormally expressed in several tumors of neuroendocrine origin. Little is known of the function of the N-myc gene product in either normal or neoplastic tissue. We utilized synthetic antisense oligodeoxynucleotides to specifically inhibit N-myc gene expression in the neuroepithelioma cell line CHP100. These cells contain single copy N-myc alleles but overexpress c-myc. N-myc antisense oligomer treatment was found to be growth inhibitory without affecting levels of c-myc protein. N-myc antisense oligomer-treated cells also lost the characteristic cellular heterogeneity displayed by CHP100 in vitro.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2205380
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701